Open Wound Research and Venture Medical Announce Collaboration to Advance Pressure Ulcer Research

Mar 11, 2025
Open Wound Research and Venture Medical Announce Collaboration to Advance Pressure Ulcer Research

Puyallup, WA – March 11, 2025 – Open Wound Research and Venture Medical, LLC have entered into a collaborative research agreement to advance the study of pressure ulcer treatment. As part of this partnership, Venture Medical has acquired extensive pressure ulcer data from Open Wound Research to evaluate the efficacy of CAMPS in comparison to standard of care (SOC) treatments.

Pressure ulcers, also known as pressure injuries or bedsores, remain a significant healthcare challenge, particularly for patients with limited mobility. Many patients suffer from hard-to-heal pressure ulcers that do not respond to extended SOC, requiring advanced treatments or alternative modalities. This research initiative aims to provide valuable insights into how CAMPS products can improve patient outcomes by enhancing wound healing.

“We are excited to collaborate with Venture Medical as their data partner on this important research,” said Zwelithini Tunyiswa, Chief Executive Officer at Open Wound Research. “By leveraging real-world data, we aim to generate clinically relevant findings that can help shape the future management of hard-to-heal pressure ulcers.”

As part of this collaboration, Open Wound Research and Venture Medical will work with leading researchers to assess the efficacy and efficiency of CAMPS products in pressure ulcer treatment. The findings are expected to contribute to evidence-based recommendations for healthcare providers treating pressure ulcer patients.

“This collaboration marks a significant step forward in our commitment to developing and distributing advanced solutions for wound care.” said John Schroeder, Chief Executive Officer at Venture Medical. “By comparing CAMPS product performance to SOC, we seek to provide healthcare professionals with data-driven insights to optimize patient care.”

The results of this research will be shared with the medical community through publications and conferences, ensuring that clinicians and researchers have access to the latest advancements in pressure ulcer treatment.

About Venture Medical, LLC: Venture Medical is a groundbreaking healthcare services company with a decade-long history of innovation, dedication, and consistent growth in the field of wound care and healing. Over the past 15 years, Venture Medical has expanded its reach across the United States and has grown to become a leading master distributor and reseller and software services provider for manufacturers and end users of biologics, advanced diagnostics, durable medical equipment, and capital goods.

For more information, visit venturemedical1.com and follow us on LinkedIn

About Open Wound Research: Open Wound Research is committed to making wound care research simpler to conduct, reproducible, and actionable for wound care stakeholders. This is accomplished by fusing clinical, research, and data science competencies to build research and data pipelines that deliver on sponsors’ needs and vision. We are also committed to open-sourcing wound care data and software to foster transparency, participation and collaboration in wound care research.

For more information, visit openwoundresearch.com.

More News & Updates

Stay Up-To-Date With
Venture Medical

Feb 12, 2025

Innovation & Adaptability: An Interview with the CEO of Venture Medical,LLC

In an industry where innovation and adaptability are key, Venture Medical, LLC has carved out a unique space, blending bold ambition with a steadfast commitment to quality and service. Over the past few years, the company has experienced exponential growth, but what truly sets Venture apart isn’t just its expansion—it’s the culture, leadership philosophy, and relentless pursuit of excellence that fuel its success.

Jan 15, 2025

The LCD Is Frozen, Now What?

On Monday during his first day in office, President Trump signed an Executive Order (EO) freezing the pending LCD policy that would limit access to skin substitutes for chronic wound care. To be clear - this is a policy freeze pending further action.

Jan 1, 2025

The Scrutiny on Skin Substitutes: Shifting The Focus From Medicare Advantage

While the top six major insurance companies have reported soaring profits—some rising by thousands of percentage points since the Medicare Advantage program was enacted, many patients enrolled in Medicare Advantage plans claim they didn’t even realize they were leaving traditional Medicare. This lack of transparency raises important questions about how these plans are marketed and the tactics used to encourage patients to switch.

Oct 28, 2024

Venture Medical announced as the exclusive US distributor of Vendaje AC ®

Venture Medical, LLC has been announced as the exclusive distributor of Vendaje AC®, a wound care product manufactured by BioStem Technologies Inc. (OTC: BSEM).

Oct 21, 2024

The Rising Costs of Wound Care: Finding Solutions Without Sacrificing Access

Under a system previously reliant solely on hospital outpatient departments, many patients—especially the elderly in care facilities, the poor, the homebound, the rural, and the otherwise disenfranchised—never enjoyed equitable access. Today, however, more patients than ever are receiving wound care as providers are motivated to bring advanced modalities directly to them.

Jan 24, 2024

MicroGen Diagnostics in Chronic Wounds

“Explore the fascinating realm of microbiology and healthcare in the MicroGenDX Mic’d Up podcast, hosted by Rick Martin, CEO of MicroGenDX. Join Rick and his special guest, the esteemed Caroline Fife, MD, FAAFP, CWS, Professor of Medicine at Baylor College of Medicine

Dec 14, 2023

Center for Medicare Services Established National Pricing of AmnioWrap2™ in All MAC Regions

The national ASP publication of AmnioWrap2™ knocks down barriers that will provide healthcare professionals and their patients with the opportunity to use AmnioWrap2™, a superior wound care product for certain applications.

Sep 7, 2022

The Gap Between Clinical Trials and Real-World Chronic Wound Patients

Caroline Fife, M.D. highlights a concerning discrepancy between the characteristics of patients with chronic wounds in real-world settings and those selected for clinical trials.

Sep 1, 2022

Demonstration of the Venture Medical Sacral Dressing Kit

Get a first-hand look at the application process of the Venture Medical Sacral Dressing Kit in this short video. We illustrate the kit's key role in protecting wounds from contaminants for patients with pressure ulcers who also suffer from incontinence. The demonstration also highlights how this kit supports the performance of advanced treatments such as CTPs. Learn to enhance your wound care practices and promote better wound healing with this cutting-edge solution.